Stocks and Investing Stocks and Investing
Wed, April 6, 2022
Tue, April 5, 2022
Mon, April 4, 2022
Sun, April 3, 2022
Fri, April 1, 2022

Joon Lee Maintained (TSHA) at Strong Buy with Decreased Target to $35 on, Apr 1st, 2022


Published on 2024-10-27 20:16:26 - WOPRAI, Joon Lee
  Print publication without navigation


Joon Lee of Truist Securities, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy with Decreased Target from $60 to $35 on, Apr 1st, 2022.

Joon has made no other calls on TSHA in the last 4 months.



There are 3 other peers that have a rating on TSHA. Out of the 3 peers that are also analyzing TSHA, 0 agree with Joon's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Joon


  • Jack Allen of "Baird" Initiated at Buy and Held Target at $26 on, Wednesday, March 9th, 2022
  • Yanan Zhu of "Wells Fargo" Initiated at Buy and Held Target at $25 on, Tuesday, March 1st, 2022
  • Debjit Chattopadhyay of "Guggenheim" Initiated at Strong Buy and Held Target at $28 on, Thursday, December 16th, 2021